Sunshine Biopharma, Inc. (SBFMW) Financials
SBFMW Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 33.6 million | 6.1 million |
| March 31, 2026 | 27.9 million | 6.4 million |
| Dec. 31, 2025 | 30.1 million | 7.0 million |
| Sept. 30, 2025 | 31.5 million | 7.3 million |
SBFMW Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -912847 | ? |
| March 31, 2026 | -2.1 million | ? |
| Dec. 31, 2025 | -845762 | ? |
| Sept. 30, 2025 | -761943 | ? |
SBFMW Net Income
No data available :(
SBFMW Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 13.7 million | - | 475820 |
| March 31, 2026 | 6.9 million | - | 535614 |
| Dec. 31, 2025 | 9.1 million | - | 596785 |
| Sept. 30, 2025 | 9.3 million | - | 854761 |
SBFMW Shares Outstanding
SBFMW Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 5131 | 13222 | 3.9 million | 209337 |
| March 31, 2026 | 5131 | 31724 | 3.3 million | 308693 |
| Dec. 31, 2025 | 770244 | -530807 | 8.7 million | 308693 |
| Sept. 30, 2025 | 34143 | 119298 | 3.3 million | 235217 |
SBFMW Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 9.3 million | 6.8 million |
| March 31, 2026 | 8.1 million | 6.0 million |
| Dec. 31, 2025 | 8.6 million | 5.6 million |
| Sept. 30, 2025 | 9.4 million | 6.3 million |
SBFMW
Price: $0.03
52 week price:
Earnings Per Share: -2.21 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 126146